The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
Open accessAbstract
BACKGROUND: Hospitalization for febrile neutropenia (FN) in cancer patients is associated with considerable morbidity, mortality, and cost. The study was undertaken to better define mortality, length of stay (LOS), cost, and risk factors associated with mortality and prolonged hospitalization in cancer patients with FN. METHODS: The longitudinal discharge database derived from 115 US medical centers was used to study all adult cancer patients hospitalized with FN between 1995 and 2000, comprising a total of 41,779 patients. Primary outcomes included mortality, LOS, and cost per episode. RESULTS: Overall, in‐hospital mortality was 9.5%. Patients without any major comorbidities had a 2.6% risk of mortality, whereas 1 major comorbidity was associated with a 10.3% and more than 1 major comorbidity with a ≥21.4% risk of mortality, respectively. Mean (median) length of stay was 11.5 (6) days, and the mean (median) cost was $19,110 ($8,376) per episode of FN. Patients hospitalized for ≥10 days (35% of all patients) accounted for 78% of overall cost. Independent major risk factors for inpatient mortality included invasive fungal infections, Gram‐negative sepsis, pneumonia and other lung disease, cerebrovascular, renal, and liver disease. Main predictors for LOS ≥10 days included leukemia, invasive fungal infections, other types of infection, and several comorbid conditions. CONCLUSION: Factors associated with increased mortality, LOS, and cost in hospitalized adult cancer patients with FN include patient characteristics, type of malignancy, comorbidities, and infectious complications. These factors may be useful in identifying patients at increased risk of serious medical complications and mortality for more aggressive supportive care measures. Cancer 2006. © 2006 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Klastersky, J., Paesmans, M., Rubenstein, E. B., Boyer, M., Elting, L., Feld, R., Gallagher, J., Herrstedt, J., Rapoport, B., Rolston, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.3038 · Cited by 1,171
Wisplinghoff, H., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2003) · Clinical Infectious Diseases · doi:10.1086/374339 · Cited by 687
Talcott, J. A., Siegel, R. D., Finberg, R., & Goldman, L. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.2.316 · Cited by 545
Elting, L. S., Rubenstein, E. B., Rolston, K. V. I., & Bodey, G. P. (1997) · Clinical Infectious Diseases · doi:10.1086/514550 · Cited by 385
Talcott, J. A. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.12.2561 · Cited by 363
Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy
Caggiano, V., Weiss, R. V., Rickert, T. S., & Linde‐Zwirble, W. T. (2005) · Cancer · doi:10.1002/cncr.20983 · Cited by 328
Lyman, G. H., Dale, D. C., Friedberg, J., Crawford, J., & Fisher, R. I. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.213 · Cited by 315
Self-citationLyman, G. H., Morrison, V. A., Dale, D. C., Crawford, J., Delgado, D. J., & Fridman, M. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000119262 · Cited by 224
Self-citation(1995) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(05)80058-6 · Cited by 197
Maher, D. W., Lieschke, G. J., Green, M., Bishop, J., Stuart-Harris, R., Wolf, M., Sheridan, W. P., Kefford, R. F., Cebon, J., Olver, I., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-7-199410010-00004 · Cited by 196
The economics of febrile neutropenia: implications for the use of colony-stimulating factors
Lyman, G. H., Kuderer, N., Greene, J., & Balducci, L. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00222-6 · Cited by 192
Self-citationGarcia-Carbonero, R., Mayordomo, J. I., Tornamira, M. V., Lopez-Brea, M., Rueda, A., Guillem, V., Arcediano, A., Yubero, A., Ribera, F., Gomez, C., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.1.31 · Cited by 177
Colony-stimulating factors for chemotherapy-induced febrile neutropenia
Mhaskar, R., Clark, O. A. C., Lyman, G., Engel Ayer Botrel, T., Morganti Paladini, L., & Djulbegovic, B. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003039.pub2 · Cited by 172
Self-citationLength of Stay and Mortality Associated With Febrile Neutropenia Among Children With Cancer
Basu, S. K., Fernandez, I. D., Fisher, S. G., Asselin, B. L., & Lyman, G. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6378 · Cited by 166
Self-citationBacteremic Pneumonia in Neutropenic Patients With Cancer
Carratalà, J., Rosón, B., Fernández-Sevilla, A., Alcaide, F., & Gudiol, F. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.8.868 · Cited by 132
Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients
Darmon, M., Azoulay, É., Alberti, C., Fieux, F., Moreau, D., Gall, J. L., & Schlemmer, B. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1528-7 · Cited by 125
González-Barca, E. M., Fernández-Sevilla, A., Carratalà, J., Grañena, A., & Gudiol, F. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01695660 · Cited by 120
Anaissie, E. J., Vartivarian, S. E., Bodey, G. P., Legrand, C., Kantarjian, H. M., Abi-Said, D., Karl, C. L., & Vadhan‐Raj, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)90006-6 · Cited by 95
Penack, O., Beinert, T., Buchheidt, D., Einsele, H., Hebart, H. F., Kiehl, M. G., Massenkeil, G., Schiel, X., Schleicher, J., Staber, P. B., et al. (2006) · Annals of Hematology · doi:10.1007/s00277-006-0096-2 · Cited by 91
Ravaud, A., Chevreau, C., Cany, L., Houyau, P., Dohollou, N., Roche, H. H., Soubeyran, P., Bonichon, F., Mihura, J., Eghbali, H., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.2930 · Cited by 51
Colony stimulating factors for chemotherapy induced febrile neutropenia
Clark, O. A. C., Lyman, G. H., Castro, A. A., Clark, L. G., & Djulbegović, B. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003039 · Cited by 44
Self-citationPrognosis of infections in elderly patients with haematological diseases
Rossini, F. (1996) · Supportive Care in Cancer · doi:10.1007/bf01769875 · Cited by 11
Cited by
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Aapro, M. S., Bohlius, J., Cameron, D. A., Lago, L. D., Donnelly, J. P., Kearney, N., Lyman, G. H., Pettengell, R., Tjan-Heijnen, V. C., Walewski, J., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.10.013 · Cited by 1,090
Self-citationKuderer, N. M., Dale, D. C., Crawford, J., & Lyman, G. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8823 · Cited by 720
Self-citationFreifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq147 · Cited by 704
Metadata
- Authors
- Kuderer, N. M., Dale, D. C., Crawford, J., Cosler, L. E., & Lyman, G. H.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2006-04-27
- Volume
- 106
- Issue
- 10
- Pages
- 2258-2266
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2083336892
- Cited by
- 1,176
- References
- 24
- FWCI
- 16.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.